Navigation Links
Drug developed at the University of Chicago wins FDA approval
Date:4/28/2008

Methylnaltrexone, a drug developed to relieve one of the major side effects of pain therapy for cancer patients, received marketing approval from the United States Food and Drug Administration on April 24, 2008, for use in the treatment of opioid-induced bowel disorders in patients receiving palliative care for advanced illness such as cancer.

The FDA's European equivalent, the Committee for Medicinal Products for Human Use, also rendered a "positive opinion" for RELISTOR on April 24. Health Canada, the Canadian Regulatory Agency, approved methylnaltrexone (to be marketed as RELISTOR) on March 28.

"This new drug will be helpful to patients who experience severe constipation associated with the continuous use of morphine or other opioids, which are an important part of care for patients with late-stage, advanced illness," said Joyce Korvick, M.D., deputy director of the Division of Gastroenterology Products at the FDA.

"It took almost 30 years but it finally seems that a very useful drug will at last become an option for those who desperately need it," said Jonathan Moss, M.D., Ph.D., professor of anesthesia & critical care at the University of Chicago Medical Center. "Patients who depend on opiates for pain relief at the end of life are often forced to curtail their opiates because of the side effects. This solves an important clinical problem for some of our most vulnerable patients."

In the United States, powerful opioid-based pain relievers--such as Percocet, OxyContin or morphine--are taken by more than 1.5 million people who suffer from advanced illness such as cancer. Although morphine and related compounds remain the gold standard for pain relief, these drugs often produce significant side effects. One of the most troubling for patients is severe constipation. This can be so distressing that many patients discontinue their pain medication. Methylnaltrexone blocks the side effects without disrupting pain relief.


'/>"/>
Contact: John Easton
john.easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Microbiotic technology developed for microinjection of zebrafish embryos
2. Lab-on-chip testing for bird flu developed by Singapore scientists
3. Mobility-enhancing device developed at University of Alberta will receive prestigious da Vinci Award
4. New Denver Area Program Developed For Teens in Crisis
5. Genomic technologies to identify toxic chemicals should be developed
6. New system for classifying infant lung disease developed
7. Cancer cell line developed that is resistant to new cancer therapy
8. Mouse Model of Age-Related Macular Degeneration Developed
9. Lab on a chip developed at University of Alberta for cheap, portable medical tests
10. Novel vaccine concept developed by scientists at the Wistar Institute
11. Novel molecules developed at UB can boost vaccine potency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Sound Telecom, a leader in the call ... people any time they wonder, “Should I use an answering ... leading them through a series of yes or no questions ... , There are many considerations and scenarios that come into ... answering service . This decision infographic serves as a bit ...
(Date:10/30/2014)... Scientists who used stem cells to create miniature human ... a new way to learn more about the development ... human pluripotent stem cells -- which can become any ... the functional miniature stomachs, to study infection by ... and stomach cancer. The miniature stomachs offer many ...
(Date:10/30/2014)... Dennis Thompson HealthDay Reporter ... of milk could be bad for your health, a new ... in milk can help strengthen bones and prevent osteoporosis. These ... recommend milk as part of a healthy diet. But ... did not protect men or women from bone fractures, and ...
(Date:10/30/2014)... 2014 (HealthDay News) -- Eating a low-carb, high-fat diet ... according to new research. A review of ... diet, that focuses on foods like bacon, eggs, heavy ... seizures in adults whose condition doesn,t improve with medication. ... of people with epilepsy whose seizures are not stopped ...
(Date:10/30/2014)... News) -- A new vaccine that could help prevent ... by the U.S. Food and Drug Administration on Wednesday. ... ages of 10 and 25 from invasive meningococcal disease ... The bacteria can infect the bloodstream (sepsis) and ... It is a leading cause of bacterial meningitis, and ...
Breaking Medicine News(10 mins):Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2
... Wake Up Call as Lighthouse International and EHE International unveil ... Thousands of New Yorkers will see a new warning sign ... of their vision. The sign, located at 10 Rockefeller Plaza ... International, a l03-year-old leader in vision healthcare. It will be ...
... meet critical needs of patients, families and staffSAN ... flagship facility of San Diego County,s most comprehensive ... expansion to become the premier referral care center ... 315,000-square-foot, 334-bed structure, named the Stephen Birch Healthcare ...
... poorer quality of lifeparticularly for adolescents. New research ... their conditions. , Two recent studies, led by ... Sian Cotton, PhD, research assistant professor in the ... inflammatory bowel disease (IBD)a condition characterized by chronic ...
... productive partnershipBALTIMORE, Jan. 8 The Medicare Advocacy ... for Medicare Secondary Payor reform, laid the groundwork ... its inaugural meeting with officials from the Center ... to introduce MARC as an industry resource to ...
... promote OTC cold and flu and ,allergy products , ... ... Inc., has selected GolinHarris as agency of record to lead its ... agency is charged with ongoing strategic counsel, product messaging, traditional media ...
... in Orlando, FL will feature strategies and tools that increase member ... ... FL (Vocus) January 8, 2009 -- Facing unprecedented marketplace disruption - ... autonomy in health insurance selection - the retention of individual and ...
Cached Medicine News:Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 3Health News:New Sharp Memorial Hospital Features All Private Patient Rooms, Expanded Emergency and Trauma Services and Family Waiting Areas 2Health News:New Sharp Memorial Hospital Features All Private Patient Rooms, Expanded Emergency and Trauma Services and Family Waiting Areas 3Health News:New Sharp Memorial Hospital Features All Private Patient Rooms, Expanded Emergency and Trauma Services and Family Waiting Areas 4Health News:Spirituality may help adolescents cope with chronic illness 2Health News:Spirituality may help adolescents cope with chronic illness 3Health News:MARC Coalition Holds Initial Meeting With CMS; Announces New Members 2Health News:Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand 2Health News:Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand 3Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 2Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 3Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 4
(Date:10/30/2014)... The global market for human vaccines ... of new vaccines. These new products and other ... The Kalorama information report examines the global market ... vaccines for diseases that are already vaccine-preventable. ... communities from diseases spread by person-to-person transmission. The ...
(Date:10/27/2014)... Calif. , Oct. 27, 2014  RenovoRx, a ... blood flow and delivery of fluids to selected sites ... Board of Directors has appointed Shaun Bagai ... of the RenovoRx Board of Directors. Bagai brings more ... industry. Bagai joined RenovoRx in June 2014 ...
(Date:10/27/2014)... 27, 2014  In the last few weeks, Ebola has gone ... to a worldwide crisis when a traveler to ... died, and two nurses were infected. While much of ... use of modern technology, such as electronic health records (EHRs), to ... This week, InformationWeek Healthcare Editor Alison Diana fills in ...
Breaking Medicine Technology:Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments 2Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments 3RenovoRx Board Names Shaun R. Bagai as CEO 2EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3
... 2012 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... leading domestic developer, manufacturer and marketer of orthopedic ... operating subsidiaries, Beijing Libeier Biology Engineering Research Institute ... Ltd, have received approvals from relevant PRC authorities ...
... MAPLE GROVE, Minn., Jan. 11, 2012  Snow tires? Check! ... Just like a car, you need to prepare your ... extreme temperature changes can result in skin that is ... brakes on severe dry skin before it starts with ...
Cached Medicine Technology:China Kanghui Holdings Renews High and New Technology Enterprises Status of Its PRC Operating Subsidiaries 2Don't Let Your Skin Take a Backseat As You Prepare for Winter 2Don't Let Your Skin Take a Backseat As You Prepare for Winter 3
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Cottle Tenaculum Skin Hook. 5 1/2" small, shallow curve....
Goldman single hook....
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl...
Medicine Products: